Author(s): Gordino, Gisela ; Costa Pereira, Sara ; Corredeira, Patrícia ; Alves, Patrícia ; Costa, Luis ; Gomes, Anita Q. ; Silva-Santos, Bruno ; Ribot, Julie
Date: 2021
Persistent ID: http://hdl.handle.net/10451/50776
Origin: Repositório da Universidade de Lisboa
Subject(s): Cancer; Effector T lymphocytes; miR-181a; microRNAs; γδ T cells
γδ T cells are a conserved population of lymphocytes that contributes to anti-tumor responses through its overt type 1 inflammatory and cytotoxic properties. We have previously shown that human γδ T cells acquire this profile upon stimulation with IL-2 or IL-15, in a differentiation process dependent on MAPK/ERK signaling. Here, we identify microRNA-181a as a key modulator of human γδ T cell differentiation. We observe that miR-181a is highly expressed in patients with prostate cancer and that this pattern associates with lower expression of NKG2D, a critical mediator of cancer surveillance. Interestingly, miR-181a expression negatively correlates with an activated type 1 effector profile obtained from in vitro differentiated γδ T cells and miR-181a overexpression restricts their levels of NKG2D and TNF-α. Upon in silico analysis, we identify two miR-181a candidate targets, Map3k2 and Notch2, which we validate via overexpression coupled with luciferase assays. These results reveal a novel role for miR-181a as critical regulator of human γδ T cell differentiation and highlight its potential for manipulation of γδ T cells in next-generation immunotherapies.
